Nanofiber sheet for regenerating and reinforcing soft tissue and method for producing same
A nanofiber sheet made of PGLA and PVP with a specific molar ratio addresses rapid biodegradation and shrinkage issues, providing effective soft tissue regeneration and reinforcement by maintaining structural integrity and biodegrading within 15 weeks.
Patent Information
- Application Number
- JP2024529789
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-10
- Filing Date
- 2021-12-10
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2041-12-10
Smart Images

Figure 2024541433000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a nanofiber sheet for regenerating and reinforcing soft tissue and a manufacturing method thereof. More specifically, the nanofiber sheet for regenerating and reinforcing soft tissue comprises a biodegradable polymer including poly(glycolic-co-lactic acid) (PGLA) and polyvinylpyrrolidone (PVP), and is characterized in that the molar ratio of glycolic acid block:lactic acid block of the poly(glycolic-co-lactic acid) (PGLA) is 30:70 to 40:60. [Background technology]
[0002] Tissue engineering is a field of regenerative medicine from cells to artificial organs, based on the science of biological and engineering techniques from biological substances to materials that can help restore tissues and organs, and is recognized as one of the important technologies in the future of life science and medicine. Various methods are being researched to achieve the goal of restoring, maintaining, and improving the body's functions by understanding the correlation between the structure and function of living tissues and creating and transplanting biological substitutes.
[0003] One of the main techniques in tissue engineering is to create supports or scaffolds that act as anchorages for cells to attach and grow. Unlike two-dimensional membranes or capsules, scaffolds are three-dimensional and refer to spaces in which all cells in the body can attach, differentiate, and proliferate.
[0004] Scaffolds play a very important role in tissue engineering, as they play a key role in the growth of cells seeded within the porous structure and cells migrating from the surrounding tissue.
[0005] The vast majority of cells in the human body are adherent cells that attach and grow, and if there is nowhere for them to attach, they cannot grow and will die, so the scaffold must provide a suitable environment for cell attachment, differentiation, growth and migration.
[0006] In addition, these scaffolds must function as a base to allow cells to adhere and form tissues with sufficient three-dimensional structure, and since they are the most fundamental element in creating artificial biological tissues, biocompatibility, biodegradability, toxicity, mechanical and structural properties must all be considered.In recent years, active research has been conducted on the development of scaffolds for tissue regeneration using natural materials, synthetic polymers, bioceramics, and polymer-ceramic composites as porous tissue engineering scaffolds.
[0007] In addition, nanostructures such as nanofibers and nanoparticles are one of the effective structures for supporting cells in soft tissues, and there are many reports that their structural advantages have a positive effect on cell proliferation, generation, and differentiation.
[0008] Therefore, the present inventors focused on the above-mentioned technology and produced a nanofiber sheet for regenerating and reinforcing soft tissue as a scaffold for tissue regeneration, thereby completing the present invention.
[0009] In general, an electrospinning system can be broadly divided into a fiber raw material solution supply section, a high voltage supply section, and a collector section where nanofibers are formed. Other spinning environments (humidity, temperature) must be maintained at optimal constant conditions. The solution supply section is composed of a syringe pump that accurately ejects the solution at a constant speed and a syringe (or nozzle) section, and the fiber characteristics can be controlled by designing the shape, diameter, material, etc. of the syringe needle. The high voltage supply section controls the voltage and current with an insulated cable composed of a (+) pole that charges the polymer solution section with a high dielectric constant and a (-) pole where the charged solution is collected in the form of nanofiber filaments. The collector section where the nanofibers are collected can adjust the arrangement of nanofiber strands by designing its shape, movement, speed, etc., and materials of various shapes according to the purpose can also be manufactured. The form of the material used for electrospinning is generally in a well-dissolved solution state, and the solution properties of the polymer used during electrospinning have a great influence on fiber formation, and such solution properties include the concentration, viscosity, surface tension, conductivity, dielectric properties, and volatility of the polymer solution. The concentration of the polymer solution is closely related to the viscosity, which is a measure of the entanglement and fluidity of polymer chains, and is therefore known to be an important factor affecting the shape, diameter, and injection speed of fibers produced during electrospinning. Although it varies depending on the polymer properties, it has been reported that fiberization is possible when the viscosity is about 0.5 to 50 poise, and fiberization does not occur if the viscosity is too high or low. Electrospinning is a technology that produces fibers of several nm to several μm by applying electrostatic force to a polymer solution or melt and spinning it with a large potential difference between a charged polymer and a grounded current collector plate. The equipment and devices are inexpensive and simple, it is possible to spin at a high spinning speed and in a small amount, it is possible to obtain a sheet shape by spinning, and it is a spinning technology that makes it easy to add additives. A technology has been proposed in which nanofibers, especially nanofibers obtained by electrospinning a polymer solution, are used as a physical barrier to prevent tissue adhesion.
[0010] Professor Benjamin Chu of the United States has attempted to manufacture biodegradable nanofibers containing antibiotics using PLGA, a commonly used tissue engineering material, as a base material, and to use them as tissue adhesion prevention membranes. However, this technology has a problem in that the main material, PLGA, is a hydrophobic polymer, and when manufactured into a nanofiber sheet, it shrinks violently in an aqueous solution (Non-Patent Document 1: Hongliang Jiang, Benjamin Chu, "Preparation and characterization of ibuprofen-loaded poly(lactide-co-glycolide) / poly(ethylene glycol)-g-chitosan electrospun membranes", J. Biomater. Sci. Polymer Edn, Vol. 15. No. 3, 279-296 2004).
[0011] A representative sheet for reinforcing and repairing soft tissues currently on the market is NEOVEIL by GUNZE. NEOVEIL is not a nanofiber product, but a fiber woven nonwoven sheet using micro-unit thermocompression bonding. NEOVEIL biodegrades rapidly after 3 weeks in the body, and there is a problem that the desired effect of regenerating and strengthening biological soft tissues cannot be obtained when it takes more than 3 weeks to regenerate and strengthen soft tissues.
[0012] In the course of research to solve the above problems, the present inventors have developed a nanofiber sheet for regenerating and reinforcing soft tissue, which comprises a biodegradable polymer including poly(glycolic-co-lactic acid) (PGLA) and polyvinylpyrrolidone (PVP), and in which the molar ratio of glycolic acid block:lactic acid block of the poly(glycolic-co-lactic acid) (PGLA) is 30:70 to 40:60. They have found that the nanofiber sheet for regenerating and reinforcing soft tissue still maintains its physical properties even after 3 weeks or more in the body, and is absorbed by the body within 15 weeks, thereby completing the present invention. [Prior art documents] [Non-patent literature]
[0013] [Non-Patent Document 1] Hongliang Jiang, Benjamin Chu, “Preparation and characterization of ibuprofen-loaded poly(lactide-co-glycolide) / poly(ethylene glycol)-g-chitosan electrospun membranes”, J. Biomater. Sci. Polymer Edn, Vol. 15. No. 3, 279-296 2004 Summary of the Invention [Problem to be solved by the invention]
[0014] The present invention has been devised to solve the above-mentioned problems of the conventional art, and has an object to provide a nanofiber sheet for regenerating and reinforcing soft tissue.
[0015] Another object of the present invention is to provide a method for producing the nanofiber sheet for regenerating and reinforcing soft tissue. [Means for solving the problem]
[0016] As a technical means for achieving the above technical objectives, one aspect of the present invention provides a nanofiber sheet for soft tissue regeneration and reinforcement, which comprises a biodegradable polymer including poly(glycolic-co-lactic acid) (PGLA) and polyvinylpyrrolidone (PVP), and in which the molar ratio of glycolic acid block:lactic acid block of the poly(glycolic-co-lactic acid) (PGLA) is 30:70 to 40:60.
[0017] The composition may contain 60 to 90 parts by weight of the poly(glycolic-co-lactic acid) (PGLA) and 10 to 40 parts by weight of the polyvinylpyrrolidone (PVP).
[0018] The average diameter of the fiber cross section may be 500 to 990 nm.
[0019] Furthermore, another aspect of the present invention provides a method for producing a nanofiber sheet for regenerating and reinforcing soft tissue, the method including: obtaining a polymer solution by dissolving a biodegradable polymer including poly(glycolic-co-lactic acid) (PGLA) and polyvinylpyrrolidone (PVP) in a solvent including dichloromethane (DCM) and dimethylformamide (DMF) to obtain a polymer solution; obtaining a nanofiber by electrospinning the polymer solution to obtain a nanofiber; and heat treating the nanofiber.
[0020] The molar ratio of glycolic acid block:lactic acid block of the poly(glycolic-co-lactic acid) (PGLA) may be 30:70 to 40:60.
[0021] The composition may contain 60 to 90 parts by weight of the poly(glycolic-co-lactic acid) (PGLA) and 10 to 40 parts by weight of the polyvinylpyrrolidone (PVP).
[0022] The solvent may contain 50 to 70 parts by weight of dichloromethane (DCM) and 30 to 50 parts by weight of dimethylformamide (DMF).
[0023] The polymer solution may contain 90 parts by weight of the solvent and 8 to 15 parts by weight of the biodegradable polymer.
[0024] The electrospinning conditions in the nanofiber obtaining step can be a voltage of 15-30 kV, a spinning distance of 10-20 cm, and a discharge rate of 0.5-2 ml / h.
[0025] The heat treatment step may be a heat treatment at 50 to 100° C. for 10 to 35 minutes.
[0026] The nanofibers may have an average cross-sectional diameter of 500 to 990 nm. Effect of the Invention
[0027] The nanofiber sheet for regenerating and strengthening soft tissue according to the present invention can maintain its physical properties even in vivo for a period of 3 weeks or more and can be absorbed by the body within 15 weeks and is harmless to the human body.
[0028] In addition, the nanofiber sheet for regenerating and reinforcing soft tissue may have reduced shrinkage in an aqueous solution. [Brief description of the drawings]
[0029] [Figure 1] 1 is a nanofiber sheet for regenerating and reinforcing soft tissue prepared according to Example (1) of the present invention, and a SEM image thereof magnified 1000 times. [Diagram 2] 1 is a SEM photograph showing a nanofiber sheet for regenerating and reinforcing soft tissue prepared according to Example (1) of the present invention at 5000 times magnification. [Diagram 3] 1 is a SEM photograph showing a nanofiber sheet for regenerating and reinforcing soft tissue prepared according to Comparative Example (1) of the present invention at 5000 times magnification. [Figure 4] 1 is a graph showing the change in tensile strength of the nanofiber sheet for soft tissue regeneration and reinforcement manufactured according to Example (1) of the present invention. [Diagram 5] 1 is a graph showing the tensile strength change of NEOVEIL brand sheets. [Figure 6] 1 is a SEM photograph showing a 5000x magnification of a nanofiber sheet for regenerating and reinforcing soft tissue prepared according to Comparative Example (4) of the present invention after 3 days of cell proliferation. [Figure 7] 1 is a SEM photograph showing a 5000x magnification of a nanofiber sheet for soft tissue regeneration and reinforcement prepared according to Example (2) of the present invention three days after cell proliferation. [Figure 8] 1 is a SEM image showing a 5000x magnification of a nanofiber sheet for soft tissue regeneration and reinforcement prepared according to Example (3) of the present invention after 3 days of cell proliferation. [Figure 9] 1 is a SEM photograph showing a 5000x magnification of a nanofiber sheet for soft tissue regeneration and reinforcement prepared according to Example (1) of the present invention after 3 days of cell proliferation. [Figure 10] 1 is a SEM image showing a 5000x magnification of a nanofiber sheet for soft tissue regeneration and reinforcement prepared according to Example (4) of the present invention after 3 days of cell proliferation. [Figure 11]1 is a SEM photograph showing a nanofiber sheet for regenerating and reinforcing soft tissue prepared according to Comparative Example (5) of the present invention at a magnification of 2500 times. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0030] The present invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein, but rather as defined by the claims set forth below.
[0031] In addition, the terms used in the present invention are merely used to describe specific embodiments and are not intended to limit the present invention. A singular expression includes a plural expression unless the context clearly indicates otherwise. Throughout the specification of the present invention, when a part "includes" a certain component, it means that the part can further include other components, not excluding other components, unless otherwise specified to the contrary.
[0032] A first aspect of the present invention provides a nanofiber sheet for regenerating and reinforcing soft tissue, which comprises a biodegradable polymer including poly(glycolic-co-lactic acid) (PGLA) and polyvinylpyrrolidone (PVP), and the molar ratio of glycolic acid block:lactic acid block of the poly(glycolic-co-lactic acid) (PGLA) is 30:70 to 40:60.
[0033] The nanofiber sheet for regenerating and reinforcing soft tissue according to the first aspect of the present invention will be described in detail below.
[0034] In one embodiment of the present invention, the nanofiber sheet for regenerating and strengthening soft tissue contains a biodegradable polymer including poly(glycolic-co-lactic acid) (PGLA) and polyvinylpyrrolidone (PVP), and thus shrinks less in an aqueous solution compared to a case where only poly(glycolic-co-lactic acid) (PGLA) is used as a biodegradable polymer, and can regenerate and strengthen soft tissue by maintaining its physical properties even after 3 weeks or more in vivo, and can be absorbed by the body within 15 weeks and is harmless to the body.
[0035] Furthermore, by using poly(glycolic-co-lactic acid) (PGLA) having a molar ratio of glycolic acid block:lactic acid block of 30:70 to 40:60, the average diameter of the nanofiber cross section can be set to 500 to 990 nm.
[0036] When the molar ratio of the glycolic acid block to the lactic acid block of the poly(glycolic-co-lactic acid) (PGLA) is less than 30 and the molar ratio of the lactic acid block is more than 70, the biodegradable polymer is not partially dissolved in the solvent, making it difficult to apply the electrospinning of the present invention, or even if nanofibers are formed, complete fiberization may not occur, and the nanofibers may have irregular thicknesses, resulting in the formation of portions with large thickness variations.
[0037] When the molar ratio of the glycolic acid block to the lactic acid block of the poly(glycolic-co-lactic acid) (PGLA) is greater than 40 and less than 60, the material is more likely to dissolve in a solvent, but the diameter of the fiber may become thinner, and therefore biodegradation in the body may proceed more quickly after electrospinning.
[0038] In one embodiment of the present invention, the average diameter of the fiber cross section may be 500 to 990 nm, preferably 550 to 850 nm, more preferably 550 to 800 nm. If the average diameter of the nanofiber cross section is smaller than 500 nm, the surface area of the nanofiber may be large, but it is difficult to form a support layer necessary for cell growth. If the average diameter of the nanofiber cross section is larger than 990 nm, the inter-fiber space may become large, which may inhibit cell growth.
[0039] A second aspect of the present invention provides a method for producing a nanofiber sheet for regenerating and reinforcing soft tissue, the method comprising: obtaining a polymer solution by dissolving a biodegradable polymer including poly(glycolic-co-lactic acid) (PGLA) and polyvinylpyrrolidone (PVP) in a solvent including dichloromethane (DCM) and dimethylformamide (DMF) to obtain a polymer solution; obtaining a nanofiber by electrospinning the polymer solution to obtain a nanofiber; and heat treating the nanofiber.
[0040] Detailed descriptions of parts that overlap with the first aspect of the present invention have been omitted, but the contents described for the first aspect of the present invention may be similarly applied even if the description is omitted in the second aspect.
[0041] Hereinafter, the method for producing a nanofiber sheet for regenerating and reinforcing soft tissue according to the second aspect of the present invention will be described in detail step by step.
[0042] First, in one embodiment of the present invention, a polymer solution obtaining step may be included in which a biodegradable polymer including poly(glycolic-co-lactic acid) (PGLA) and polyvinylpyrrolidone (PVP) is dissolved in a solvent including dichloromethane (DCM) and dimethylformamide (DMF) to obtain a polymer solution.
[0043] In one embodiment of the present invention, the molar ratio of the glycolic acid block to the lactic acid block of the poly(glycolic-co-lactic acid) (PGLA) may be 30:70 to 40:60.
[0044] In one embodiment of the present invention, the poly(glycolic-co-lactic acid) (PGLA) may be contained in an amount of 60 to 90 parts by weight and 10 to 40 parts by weight of the polyvinylpyrrolidone (PVP). If the amount of the polyvinylpyrrolidone (PVP) is less than 10 parts by weight, a secondary fixation step using sutures or tissue adhesive may be necessary when the nanofiber sheet is applied to the soft tissue. Therefore, if the amount of the PVP is less than 10 parts by weight, the sheet may be detached from the soft tissue unless a process for fixing the sheet to the soft tissue is performed. If the amount of the polyvinylpyrrolidone (PVP) is more than 40 parts by weight, the soft tissue may not be regenerated.
[0045] In one embodiment of the present invention, the solvent may contain 50-70 parts by weight of dichloromethane (DCM) and 30-50 parts by weight of dimethylformamide (DMF). If the amount of dimethylformamide (DMF) is less than 30 parts by weight, the biodegradable polymer may not be dissolved to an extent that allows electrospinning. If the amount of dimethylformamide (DMF) is more than 50 parts by weight, the biodegradable polymer may not be significantly dissolved.
[0046] In one embodiment of the present invention, the polymer solution may contain 8 to 15 parts by weight of the biodegradable polymer with respect to 90 parts by weight of the solvent. If the biodegradable polymer is less than 8 parts by weight, the nanofiber cross-sectional diameter may be less than 500 nm, and the nanofiber sheet may be damaged even by a small impact. If the biodegradable polymer is more than 15 parts by weight, the nanofiber cross-sectional diameter may be less than 990 nm, and when the nanofiber sheet is applied to soft tissue, regeneration of the soft tissue may not be effectively performed.
[0047] Meanwhile, in one embodiment of the present invention, the electrospinning conditions of the nanofiber obtaining step may be a voltage of 15-30 kV, a spinning distance of 10-20 cm, and a discharge speed of 0.5-2 ml / h. If the voltage, spinning distance, and discharge speed are outside the above ranges, the average cross-sectional diameter of the nanofibers may be smaller than 500 nm or larger than 990 nm.
[0048] Meanwhile, in one embodiment of the present invention, the heat treatment step may be a heat treatment at 50-100°C for 10-35 minutes. The reason for the heat treatment is that the nanofiber sheet may shrink in the living body, so that the nanofiber sheet can survive in the living body for 3 to 15 weeks by shrinking the nanofiber sheet through the heat treatment. If the temperature and heat treatment time of the heat treatment step are outside the range, the strength of the nanofibers may be reduced, and the nanofiber sheet may not be able to survive in the living body for 3 to 15 weeks.
[0049] On the other hand, the average diameter of the cross section of the nanofibers may be 500 to 990 nm.
[0050] DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention may be embodied in various different forms and should not be construed as being limited to the embodiments set forth herein.
[0051] Material preparation
[0052] A total of three types of poly(glycolic-co-lactic acid) (PGLA) were used. PGLA with a molar ratio of glycolic acid block (G):lactic acid block (L) (G:L) of 9:1 was purchased from Meta Biomed, and Glacomer 91 was used. PGLA with G:L=5:5 was purchased from Joinsmed. The molecular weight was 54,000 to 69,000. PGLA with G:L=35:65 was purchased from CUREBIOTECH, and Curesorb-PGLA3565 was used. Polyvinylpyrrolidone (PVP) was purchased from Sigma Aldrich, and the upper molecular weight was 1,300,000.
[0053] 1. Example (1)
[0054] 1. Polymer solution preparation step
[0055] (1) A biodegradable polymer was produced by mixing PGLA (G:L=35:65) and PVP (70:30) in a weight ratio.
[0056] (2) A solvent was prepared by mixing dichloromethane (hereinafter referred to as DCM) and dimethylformamide (hereinafter referred to as DMF) in a weight ratio of 60:40.
[0057] (3) 11 parts by weight of the above biodegradable polymer was dissolved in 89 parts by weight of the above solvent to obtain a polymer solution.
[0058] 2. Nanofiber Acquisition Steps
[0059] The polymer solution was electrospun at a voltage of 20 kV, a spinning distance of 15 cm, and a discharge rate of 1 ml / h to produce nanofibers.
[0060] 3. Heat treatment step
[0061] The nanofibers were subjected to heat treatment in an oven under the conditions of a heat treatment temperature of 75 to 85° C. and a heat treatment time of 30 minutes.
[0062] 1 and 2, it can be seen that the average diameter of the nanofiber cross section of the nanofiber sheet of the present invention is 500 to 990 nm.
[0063] 2. Comparative Example (2)
[0064] This example was the same as Example (1) except that PVP was changed to poly(ethylene oxide) (hereinafter referred to as PEO) and the electrospinning voltage was changed to 18 kV.
[0065] [Table 1]
[0066] Referring to FIG. 3, it can be seen that when the composition of the biodegradable polymer is changed to PGLA and PEO, the diameter of the nanofibers becomes larger than 990 nm.
[0067] 3. Comparative Example (2)
[0068] This is the same as Example (1) above, except that PGLA with G:L=5:5 was used.
[0069] 4. Comparative Example (3)
[0070] This is the same as Example (1) above, except that PGLA with G:L=9:1 was used.
[0071] 5. Comparative Example (4)
[0072] This was the same as Example (1) above, except that the amounts of PGLA and PVP in the polymer solution obtaining step were changed to 100 parts by weight and 0 part by weight, respectively.
[0073] 6. Example (2)
[0074] This was the same as Example (1) above, except that the polymer solution was obtained by changing the amounts of PGLA to 90 parts by weight and PVP to 10 parts by weight.
[0075] 7. Example (3)
[0076] This was the same as Example (1) above, except that the amounts of PGLA and PVP used in the polymer solution obtaining step were changed to 80 parts by weight and 20 parts by weight, respectively.
[0077] 8. Example (4)
[0078] This was the same as Example (1) above, except that the polymer solution was obtained by changing the amounts of PGLA and PVP to 60 parts by weight and 40 parts by weight, respectively.
[0079] 9. Comparative Example (5)
[0080] The above Example (1) was repeated except that the weight mixture ratio of the solvent dichloromethane (hereinafter referred to as DCM) and dimethylformamide (hereinafter referred to as DMF) was changed from 60:40 to 20:10, using dimethylacetamide and acetone.
[0081] The molar ratios of G and L, the weight contents of PGLA and PVP, and the suitability for electrospinning of the remaining Examples (1) to (4) and Comparative Examples (2) to (4) excluding the above Comparative Examples (1) and (5) are summarized in Table 2 below.
[0082] [Table 2]
[0083] Referring to Table 2, it can be seen that electrospinning is not possible when G:L=5:5 or 9:1.
[0084] Experimental Example 1. Biodegradation test of Example (1)
[0085] To observe the biodegradability of the sheets, biodegradation test samples were prepared for the nanofiber sheet prepared according to Example (1) of the present invention and the sheet of NEOVEIL brand of GUNZE Co., Ltd. Samples were prepared by weighing out 0.3g, and the samples to be tested after 7, 14, 21, and 28 days were labeled as Day 7, 14, 21, and 28. A total of 12 samples were prepared, three for each level.
[0086] The sheet was then left in a water bath at 36.5°C PBS. It was then taken out and dried every 7, 14, 21, or 28 days depending on the leveling number, and placed in a vacuum oven for a set period of time. The sheet was then weighed to see how much it had lost weight compared to the initial weight.
[0087] The test results of Experimental Example 1 are shown in Table 3 below.
[0088] [Table 3]
[0089] Referring to Table 3 above, it was confirmed that the NEOVEIL brand sheet rapidly decomposed from 3 weeks onwards, and was decomposed by 52.89% after 4 weeks, which was about 10 times more than the nanofiber sheet prepared according to Example (1) of the present invention.
[0090] Experimental Example 2. Tensile strength test of Example (1)
[0091] The nanofiber sheet manufactured according to Example (1) of the present invention and the sheet of NEOVEIL brand of GUNZE were prepared as test pieces with a size of 0.5cm x 10cm. The test pieces were labeled as Day 7, 14, 21, and 28 for the samples to be tested after 7, 14, 21, and 28 days. A total of 25 pieces were prepared, 5 pieces for each level. The sheets were then left in PBS at 36.5°C in a water bath. They were then taken out and dried every 7, 14, 21, and 28 days according to the number of levelings. The tensile strength of the sheets was measured using UTM with a load cell of 100N and an extension speed of 5mm / min.
[0092] The test results of Experimental Example 2 are shown in Table 4 below.
[0093] [Table 4]
[0094] Referring to Table 4, it can be seen that the NEOVEIL brand sheet has a lower tensile strength from the beginning of the test than the nanofiber sheet prepared according to Example (1) of the present invention. Also, referring to Figures 4 and 5, it can be seen that the tensile strength of the NEOVEIL brand sheet decreases faster than the tensile strength of the nanofiber sheet prepared according to Example (1) of the present invention.
[0095] Experimental Example 3. Cell culture test of Example (1)
[0096] A total of five samples of PLGA (65:35) + PVP (0%, 10%, 20%, 30%, 40%) were subjected to cell culture. First, the sheet was punched out to the size of a 12-well plate, and both sides of the sheet were UV sterilized for 30 minutes each. Then, the sheet was placed in the 12-well plate, and PBS was poured in to wet the sheet. After immediate suction of the PBS, a glass ring was placed, and cells and medium were seeded at a ratio of 50,000 cells / 2 mL. After 1, 3, 5, and 7 days, PBS containing 2.5% glutaraldehyde was added, and cells were fixed at room temperature for 30 minutes. To remove glutaraldehyde, the sample was washed three times with PBS and then three times with sterile water. The dehydration process was carried out using 2 mL each of 50, 70, and 90% EtOH at room temperature. The sample was dried in a clean bench for 24 hours.
[0097] Referring to Figures 6 to 10, it can be seen that when the nanofiber sheet contains 0 to 30 parts by weight of PVP, cell proliferation is smooth, but when the content is 40 parts by weight, cell proliferation is insufficient.
[0098] Experimental Example 4. Annealing shrinkage test of Example (1)
[0099] The shrinkage experiment was performed by cutting the sheet into 2 x 2 cm pieces, annealing it at temperatures ranging from 70°C to 120°C for 30, 60, and 90 minutes, and then immersing it in PBS at 37°C for 7 days. The shrinkage rate of the sheet was then calculated.
[0100] The test results of Experimental Example 4 are shown in Table 5 below.
[0101] [Table 5]
[0102] Referring to Table 5 above, it can be seen that when the heat treatment is carried out at 80° C. or higher, the shrinkage rate is stable.
[0103] 11, when the composition of the solvent of the present invention is changed to a weight ratio of 20:10 of dimethylacetamide and acetone, the diameter of the cross section of the nanofiber becomes irregular and varies greatly. In addition, melting of the nanofiber is observed when heat-treated at 120°C or higher.
[0104] Although the present invention has been described in detail above with reference to the drawings and preferred embodiments, the scope of the technical idea of the present invention is not limited by these drawings and embodiments. Therefore, various modifications or equivalent embodiments may exist within the scope of the technical idea of the present invention. Therefore, the scope of the technical idea of the present invention is interpreted by the claims, and the technical idea within the scope of the equivalent or equivalent range belongs to the scope of the present invention. [Industrial Applicability]
[0105] The nanofiber sheet for regenerating and strengthening soft tissue according to the present invention can maintain its physical properties even in vivo for a period of 3 weeks or more and can regenerate and strengthen soft tissue, and can be absorbed by the body within 15 weeks and is harmless to the human body.
[0106] In addition, the nanofiber sheet for regenerating and reinforcing soft tissue may have reduced shrinkage in an aqueous solution.
Claims
1. Biodegradable polymers include poly(glycolic-co-lactic acid) (PGLA) and polyvinylpyrrolidone (PVP), The molar ratio of the glycolic acid block to the lactic acid block of the poly(glycolic-co-lactic acid) (PGLA) is 30:70 to 40:
60. A nanofiber sheet for regenerating and reinforcing soft tissue.
2. The poly(glycolic-co-lactic acid) (PGLA) is mixed with 60 to 90 parts by weight of the polyvinylpyrrolidone (PVP) in an amount of 10 to 40 parts by weight. The nanofiber sheet for regenerating and reinforcing soft tissue according to claim 1.
3. The average diameter of the fiber cross section is 500 to 990 nm. The nanofiber sheet for regenerating and reinforcing soft tissue according to claim 1.
4. a step of obtaining a polymer solution by dissolving a biodegradable polymer including poly(glycolic-co-lactic acid) (PGLA) and polyvinylpyrrolidone (PVP) in a solvent including dichloromethane (DCM) and dimethylformamide (DMF) to obtain a polymer solution; A nanofiber obtaining step of electrospinning the polymer solution to obtain nanofibers; and a heat treatment step of heat treating the nanofibers. A method for producing a nanofiber sheet for regenerating and reinforcing soft tissue, comprising:
5. The molar ratio of the glycolic acid block to the lactic acid block of the poly(glycolic-co-lactic acid) (PGLA) is 30:70 to 40:
60. A method for producing the nanofiber sheet for soft tissue regeneration and reinforcement according to claim 4.
6. The poly(glycolic-co-lactic acid) (PGLA) is mixed with 60 to 90 parts by weight of the polyvinylpyrrolidone (PVP) in an amount of 10 to 40 parts by weight. A method for producing the nanofiber sheet for soft tissue regeneration and reinforcement according to claim 4.
7. The solvent contains 50 to 70 parts by weight of dichloromethane (DCM) and 30 to 50 parts by weight of dimethylformamide (DMF). A method for producing the nanofiber sheet for soft tissue regeneration and reinforcement according to claim 4.
8. The polymer solution contains 8 to 15 parts by weight of the biodegradable polymer relative to 90 parts by weight of the solvent. A method for producing the nanofiber sheet for soft tissue regeneration and reinforcement according to claim 4.
9. The conditions of the electrospinning in the nanofiber obtaining step are a voltage of 15 to 30 kV, a spinning distance of 10 to 20 cm, and a discharge rate of 0.5 to 2 ml / h. A method for producing the nanofiber sheet for soft tissue regeneration and reinforcement according to claim 4.
10. The heat treatment step is performed at 50 to 100° C. for 10 to 35 minutes. A method for producing the nanofiber sheet for soft tissue regeneration and reinforcement according to claim 4.
11. The average cross-sectional diameter of the nanofibers is 500 to 990 nm. A method for producing the nanofiber sheet for soft tissue regeneration and reinforcement according to any one of claims 4 to 10.
Citation Information
Patent Citations
Multilayered nanofibrous anti-adhesion membranes containing hydrophilic natural polymer and preparation method thereof
KR101578535B1
Biodegradable absorbents and methods of preparation
US20030069369A1
Electrospun matrix and method
US20210128792A1
